Dose finding study to assess the efficacy and safety of SK-PC-B70M in patients with mild to moderate Alzheimer's disease
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2010
At a glance
- Drugs SK-PC-B70M (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 16 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Feb 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 13 Nov 2008 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.